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Objective: Periodontal disease (PD) is common and increases cardiovascular diseases. 
However, it is unclear whether PD is associated with increased risk of dementia. We carried 
out a systematic review and meta-analysis to investigate the influence of PD on dementia. We 
projected the number of dementia cases to be saved by reducing PD prevalence in the world.  
Method: We searched cohort and case-control studies reporting the association of PD with 
all dementia (or any specific type of dementia) through PubMed, MEDLINE, PsycINFO, 
SocINDEX, CINHAL, and CNKI until 7th November 2018. Five cohorts and seven case-
control studies were identified for review. We pooled eligible data to calculate relative risk 
(RR) of dementia in relation to PD and computed the number of dementia cases saved 
through reducing PD prevalence.  
Results: Of 12 studies, six were undertaken in Asia, four in Europe and two in America. 
Eleven studies showed a positive association between PD and the risk of dementia, of which 
10 were significant, and one reported a non-significant inverse association. Overall their 
quality was good. Pooled RR of dementia in relation to PD from all high quality studies was 
1.38 (95%CI 1.01-1.90); in the five cohorts was 1.18 (1.06-1.31) and in the two case-control 
studies 2.25 (1.48-3.42).  A 50% reduction in the current prevalence of 20% of PD in the 
population could save 850,000 (630,000-1,420,000) patients with dementia in the world.  
Conclusions: PD could increase the risk of incident dementia. Preventing and treating PD 
could contribute to controlling the global epidemic of dementia.  





Introduction   
Periodontal disease (PD) is a chronic inflammatory disease, affecting the gums by infection 
of oral bacteria resulting in alveolar bone loss and eventually tooth loss  [1]. PD includes both 
gingivitis and periodontitis, while periodontitis alone has been reported to be the sixth most 
prevalent condition worldwide, affecting around 20-50% of the global population [2].  
PD can start from early life and then progress to chronic periodontitis in the 40-50 
year age range [3]. Dental plaque (bacterial biofilm) forms on teeth and calcifies to become 
dental calculus, on which additional plaque can form. Sub-gingival biofilm and calculus 
cause PD [4] . As a source of chronic inflammation and bacterial infection, PD may affect 
other organ systems. There is evidence that PD increases the risk of  cardiovascular diseases  
and all-cause mortality [5]. However, it is not clear whether PD is associated with increased 
risk of dementia. The current literature has shown inconsistent findings; some studies 
reported a significant increase in the risk of dementia among people with PD [6-9], and others 
did not [10]. Previous systematic reviews of the literature of PD and dementia [11, 12]  have 
been limited by the inclusion of ineligible  studies (one cross-sectional design [13], and 
another examined MCI rather than dementia [14]) or omission of articles [7, 10]. In this 
paper, we carry out what is to our knowledge the most comprehensive systematic literature 
review and a meta-analysis to investigate the association of PD with risk of developing 
dementia in population-based studies, and estimate the number of people to be saved from 
suffering dementia through preventing and treating PD in the world.    
Methods 
We (RN, JT and AB) searched MEDLINE, PubMed, CINAHL, PsycINFO and SocINDEX 
databases. Based on our unique position and increased prevalence of dementia in China [15], 
we (JT, RC) also searched a China National Knowledge Infrastructure (CNKI) database as 
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done previously [16]. The strategy for the database search was developed using the outlines 
of PICO: Population (adult patients having PD/or dementia), Intervention or exposure (PD), 
comparison (patients without PD in control) and outcome (dementia or any specific type of 
dementia) [17]. In each database search, we used the search terms: (oral health or oral 
hygiene or dental health or tooth loss or periodontal disease or periodontitis or gingivitis or 
periodontal infection or caries) AND (dementia or Alzheimer’s disease or vascular dementia 
or cognitive impairment). The literature was searched from the earliest date to 7th November 
2018 to identify topic-related articles including all studies with no language restriction. We 
read the title and abstract of the searched studies. Studies were included in the systematic 
review if they were original research published in peer-reviewed journals that met the criteria 
as follows.  The study was (1) to investigate an association of PD with dementia or any type 
of dementia, (2) a cohort or case-control study from all settings including  community-
dwelling, care home or hospital, (3) to report any of the following periodontal parameters: 
periodontal pocket depth (PPD), clinical attachment loss (CAL), community periodontal 
Index (CPI), bleeding on probing (BOP), American Academy of Periodontology 
classification (AAP) and International Classification of Diseases, Ninth Revision, Clinical 
Modification codes 523.0-523.5 (ICD-9-CM), and (4) to have dementia diagnosis criteria and 
procedure elaborated. The grey literature was explored, including contact with the authors of 
potential eligible articles, e.g., non-English studies [18, 19]. Studies were excluded if they 
were a cross-sectional study, a case-report, commentaries, editorial, review, animal studies, 
or had the outcome of interest as mild cognitive impairment (MCI) only. 
Searching six electronic datasets for literature, we had 3,099 hits. After eliminating 
duplicates, 1,829 remained. Review of titles and abstracts identified 17 articles that were 
potentially relevant. Detailed examination excluded other 5 articles and left a final number of 
5 
 
12 studies (five cohort studies and seven case-control studies) [6-10, 18-24]  met the 
inclusion criteria for this systematic review (see the details in Figure 1). 
The review was conducted according to the PRISMA guidelines [17]. Two pairs of 
reviewers (RN/JT and SY/AB, each pair including a dental professional) independently 
extracted data and assessed the quality of these studies. Discrepancies were resolved through 
face-to-face discussion, and where the differences remained, a 3rd reviewer (RC) made the 
final judgement. Following our previous study of systematic literature review of dementia in 
relation to overweight and obesity [25], we developed a standardized form to extract the 
following data from the selected articles: author, year of publication, study location, study 
design, participants’ age range, sample size, measurement of PD, criteria of dementia 
diagnosis, the number of  dementia cases in outcome, data analyses, variables adjusted and 
findings. We used the Newcastle-Ottawa Scale (NOS) [26] to assess the quality of the cohort 
and case-control studies separately. A star was assigned if there was a quality feature; scores 
of 1-9 were distributed (the comparability domain can score 1-2 stars). Studies with NOS 
scores of 1 to 3 were defined as poor quality, 4 to 6 intermediate and 7 to 9  high [26]. 
Meta-analysis 
We pooled data of relative risk (RR) and its 95% Confidence Intervals (CIs) of dementia in 
relation to PD from each of the cohort or case-control studies. Since the odds ratio (OR) in 
the case-control study may overestimate the relative risk of dementia in relation to PD, we 
used a formula proposed by Zhang and Yu [27]  to convert the OR into the RR. We analysed 
the data of each studied population from these articles as we did previously [28]. We pooled 
data, where available for, all types of dementia first (if the studied population did not provide 
data of all dementia, its subtypes data would be used), and then for Alzheimer’s disease (AD) 
and vascular dementia (VaD) separately.  If the study presented data of RRs for different 
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group of PD measured [7, 10, 21] or severity level of PD we took each individual RR for 
pooling data. In studies where RR of dementia in relation to PD was not presented, we 
calculated crude RR and its 95%CIs if the study provided necessary data. All these measures 
and their 95%CIs were pooled together as a relative risk (RR) with the assumption of 
attaining a common unit of comparison. RR was estimated using a random effect model, 
provided there was a statistically significant heterogeneity, indicative of differences among 
included studies; else, a fixed effect model. We used funnel plots to assess small-study 
effects, and evaluated the possibility of publication bias using Egger’s regression asymmetry 
test [29]. 
We incorporated all studies which provided adjusted RR for the main analysis. We 
conducted subgroup analyses in terms of cohort and case-control studies, location of country 
(continents) and PD severity. We ran sensitivity analyses to evaluate the influence of studies 
with extreme value RRs and also the association of PD with dementia after including studies 
which had crude RR data.  
Using the figure of the pooled RR of dementia in relation to PD, we estimated the 
number of dementia cases in the world that could be prevented by reducing PD prevalence, 
according to previous studies of preventable risk factors for dementia [30]. Currently there 
are approximately 50 million people suffering from dementia in the world [31]. The WHO 
Global Oral Health Data Bank [32] indicated that the prevalence of PD in population aged 
35-44 years was around 5-20%, while a recent publication has suggested that  20-50% of the 
global population are affected by PD [2]. Thus we took 20% of PD occurring in a population 
of aged <65 years and computed the number of dementia cases that could be prevented if the 
current PD prevalence in the world could be halved through prevention or treatment of PD 
(i.e., the prevalence would be 10%) or it could be reduced to be at 5%. Population attributable 
risk (PAR) was estimated by multiplying the current PD prevalence estimated by 0.90 and 
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0.95 respectively and subtracting the revised number attributable cases from the original 
cases [30].  




The identified 12 studies were published between 2012 and 2018, and 11 were in English and 
one in Chinese [19]. Six were conducted in Asia [6-9, 19, 24], four in Europe [10, 18, 20, 21], 
and two in America (North America [22] and South America [23] each). Nine studies were 
from high-income countries/regions (HICs) [6-10, 18, 20-22], and three studies [19, 23, 24] 
were from middle-income countries (MICs). Of the 12 studies, five were cohort studies [6-
10], and their baseline ages of participants ranged from 20 to 80 years, sample size varied 
from 405 to 182,747, and were followed up between 10 and 15 years. Seven others were 
case-control studies [18-24], with sample sizes varied from 59 to 409 participants. The 
characteristics of 12 studies are shown in Supplementary Tables 1 and 2. 
   Six studies diagnosed PD by using PPD [18-23], of which 5 studies further examined BOP 
for diagnosis [18-22]. Among these six studies, three studies also used  CAL [19, 21-23], two 
studies used AAP criteria [22, 23] and one study used both CAL and CPI [19]. In six other 
studies [6-10, 24], four studies used ICD-9-CM codes [6-9] and two studies did evaluation 
only by CPI [10, 24].  
   Of 12 studies, six studies analysed data of all types of dementia in relation to PD [6, 7, 9, 
10, 21, 24], of which four studies further examined AD [7, 9, 10, 21] (among which two also 
examined VaD [7, 9]). In the studies measuring all types of dementia, three used Diagnostic 
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and Statistical Manual of Mental Disorders (DSM III, IV) [9, 10, 21] and two used ICD-9-
CM  codes [6, 7] to make dementia diagnosis. One case-control study [24] did not report the 
details of the methods of dementia diagnosis, but chose participants who were recruited with 
dementia diagnosed by medical doctors.  
     In six other studies which did not measure data from all types of dementia, five focused on 
AD  [8, 19, 20, 22, 23] and one  measured VaD [18]. In all, there were nine studies with an 
outcome of AD and three with VaD. In the studies of measuring AD, four used the National 
Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s 
Disease and Related Disorders Association- Alzheimer's Criteria (NINCDS-ADRDA) [10, 
21-23], and three used ICD-9-CM codes [7-9]. One study used National Institute on Aging 
and Alzheimer's Association guidelines (NIA-AA) [20], and one used the clinical diagnostic 
criteria [19] for  AD diagnosis. In three studies of VaD diagnosis, two used  ICD-9-CM  [7, 
9] and one made the diagnosis from medical specialist through imaging evidence of 
cerebrovascular disease and additional clinical features [18].  
    The overall quality of these studies was good, with a mean score of 7.75 (Table 1). In the 
five cohort studies, one had a low risk of bias with 8 scores (13) and four got a full score of 9 
points [6-9]. In the case control studies, five had low risk of bias reaching between 7-8 points 
[18-21, 23] and two had an intermediate risk of bias with 5 and 6 scores on Newcastle-
Ottawa scale [22, 24].  
   In the 12 studies, 11 [6-9, 18-24] reported a positive association of PD with dementia 
(Supplementary Table 1 and 2), of which 10 were significant [24],  while one study [10] 




One study [22] did not yield any data available for the meta-analysis, while  four studies [18, 
19, 23, 24] provided crude data enabling only calculation of unadjusted risk of dementia in 
relation to PD. All of these studies were case-control (see Supplementary Table 2). Thus, 
seven studies [6-10, 20, 21], which provided multiple adjusted RR and 95% CIs of dementia, 
were used for meta-analysis. They included 13 studied populations for data analysis (Figure 
2). The pooled data showed an overall significant association of PD with dementia (RR 1.38, 
95% CI 1.01-1.90). There is no publication bias according to the Eggers’ method (p=0.953) 
(Figure 3).                                                                                                                                                                         
Subgroup analysis 
Among the 13 studied populations, analysis of the 10 from cohort studies showed a RR of 
1.18 (1.06-1.31) for incident dementia in relation to PD, and the three from case-control 
studies showed a RR of 2.25 (1.48-3.42) (Figure 2). 
In analyses within geographical regions, pooled data of six studied populations in 
Asia showed an increased RR of 1.20 (1.08-1.33) for dementia in relation to PD, and of seven 
studies in Europe was 1.38 (0.84-2.27) (Table 2).         
Sensitivity analysis 
In Figure 3, we found one case-control study [20] had an extreme value of RR, and after 
excluding it the overall RR was 1.25 (1.11-1.40) (in the case-control 1.81, 1.35-2.43).  
    Four studies [18, 19, 23, 24] provided us with crude data to calculate unadjusted OR (see 
Supplementary Table 2). Pooling these four with above seven studies, we obtained an overall 
RR of 1.65 (1.28-2.13) (see Supplementary Figure 1). Of these 11 studies, six studies [7, 10, 
19, 21, 23, 24] provided “dose-response” data in terms of three levels of PD. Table 3 showed 
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a pooled data of dose-response relationship; compared to no/minor PD, risk of dementia in 
moderate PD was 1.39 (0.97 – 1.99) and severe PD was 1.50 (0.97 – 2.33).  
Estimated number of dementia cases prevented by reducing PD 
Given the current prevalence of PD of 20%  [2, 32], we estimated a Population Attributable 
Risk (PAR) of 3.47% of the total dementia cases worldwide, i.e., 1.735 million patients. 
Based on these estimates, a 50% reduction in the current prevalence of PD, i.e., 10%, could 
potentially reduce the number of people with dementia nearly 0.85 million cases worldwide; 
a 75% reduction in the current prevalence of PD, i.e., 5%, could remove 1.29 million people 
with dementia in the world (Table 4).  
Discussion  
We performed a comprehensive systematic review and a meta-analysis to evaluate the 
influence of PD on the risk of dementia in the population. Identifying and reviewing 12 peer-
reviewed articles we found that there was an overall significant and positive association of 
PD with increased dementia. Data of seven studies which provided adjusted RR of dementia 
in relation PD showed a pooled RR of 1.38 (1.01-1.90); in the cohort study 1.18 (1.06-1.31) 
and in the case-control studies 2.25 (1.48-3.42). If the current prevalence of PD in the 
population could be halved, 850,000 dementia cases could be prevented globally. 
Association between PD and dementia  
In older adults, PD and dementia are more prevalent. Recent studies have linked these two 
diseases as both have possible common pathophysiological mechanisms (e.g., systematic 
inflammation) [33, 34]. Although an earlier cross-sectional study in USA [35] reported no 
statistically significant differences in any of the three periodontal parameters between AD 
patients and controls, recent research suggested a significant relationship between PD and 
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dementia. A cross-sectional study in India reported that all evaluated periodontal parameters 
were higher in people with dementia compared to those without dementia [36]. In Finland, 
Syrjala et al carried out a cross-sectional study of 354 participants age >75 years, and 
observed that people with AD or other types of dementia were more likely to have carious 
teeth, teeth with deep periodontal pockets, poor oral hygiene, and denture hygiene compared 
with non-demented people [13]. In a recent systematic literature, Kapellas et al [12]  found a 
significant association of dementia with PD, but the association of PD with dementia has not 
well been investigated. 
       Some investigators tried to extract the evidence of the influence of PD on increased risk 
of incident dementia.  In 2017, Leira and colleagues published a “systematic literature review 
and meta-analysis” paper, and reported that there was an increased risk of Alzheimer’s 
disease in relation to PD; a pooled RR of 1.69 (1.21–2.35) [11]. However, although the 
authors claimed the paper as “systematic literature review”, they did miss one eligible study 
[22] in the review, but included one cross-sectional study [13], which was unable to speak to 
the incidence of dementia in relation to PD. Recently Kapellas et al [12] also carried out a 
systematic literature review and a meta-analysis on the topic using the four cohort studies [6, 
8, 9, 14]. Their meta-analysis for the cohort studies of PD predicting dementia missed two 
important studies [7, 10], but included one ineligible study which measured MCI rather than 
dementia [14].         
     
Strength and Limitations of the Current Study 
As far as we know, our study is the first to report the influence of PD on the risk of dementia 
in terms of reduced PD prevalence associated with the number of people with dementia. It 
has comprehensively searched topic-related literature and identified all eligible studies, based 
12 
 
on our mixed team’s expertise on dental and epidemiology, including from non-English 
literature and research thesis [37] for systematic review and meta-analysis to investigate the 
impact of PD on the risk of  dementia. The previous literature review [11, 12] included one 
cross-sectional study, which could not tell the causal-result relationship [13], and one study 
of examining MCI, which could not tell the influence of PD on dementia [14]. Strictly 
following PRISMA guidelines our review team (consisting of researchers with dental and 
epidemiology backgrounds) included neither the cross-sectional study nor the MCI paper for 
the systematic literature review and meta-analysis; otherwise, our pooled RR would be higher 
as the previous meta-analysis studies did [11, 12]. We also carried out the subgroup and 
sensitivity analyses. The findings of our study are robust.  
Our study has limitations. First, the studies which we identified for review used 
different measurements of PD, which gave various information on PD, including its severity. 
There is no consensus regarding PD criteria, and to measure PD different cases definitions 
are used. The variation in the methods of measuring PD in the studies might influence our 
pooled data findings, but we could not analyse them separately due to the small number of 
studies in each of those methods. However, six of 12 studies provided the data of different 
measures of PD, giving moderate (acute) and severe (chronic) stages, and showed that there 
was slightly increased influence of severe PD on the risk of dementia compared to those 
moderate PD (Table 3). Other studies included in the meta-analysis consisted of a population 
of patients with PD at different stages except for one [8]. Thus the varied PD measures in 
those studies would not substantially change our current findings. With regards to different 
procedures for measuring dementia, we could not examine their impacts on the association of 
PD with increased risk of dementia, including separate data analysis due to the small number 
of studies. But all methods of diagnosing dementia in those studies are validated. Thus the 
impact of variation in diagnosing dementia on the association between PD and dementia 
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would be minimised. Second, three studies [19, 21, 24] included patients with minor PD in 
the reference group for analysis. This would attenuate the association. Also the authors of that 
study [21] combined 159 cases of dementia with 21 patients who had mild cognitive 
impairment as the case group for analysis, and this 11.7%  misclassification may attenuate the 
association. Our finding of the influence of PD on the risk of incident dementia could be 
more conservative. Third, the adjusted confounders varied with the studies. Each of the 
studies adjusted for different sets of confounders, except four studies [18, 19, 23, 24]  which 
only presented the crude data for calculating the RR. The adjusted confounders are not 
consistent across the studies (Supplementary Tables 1 and 2). In our meta-analysis, we 
included seven studies [6-10, 20, 21]  which adjusted for confounders to  produce the main 
findings. They adjusted for 7-12 numbers of most important confounders such as age, sex, 
socioeconomic status, lifestyles, social network and co-morbidities. We have found no 
association between the number of adjusted confounders and RR. In spite of it, only one 
study among these studies which adjusted for confounders included smoking for adjustment. 
The residual effect from smoking remained, which may lead the influence of PD on dementia 
towards hypothesis. But the studies adjusted for other smoking-related factors such as 
socioeconomic status and co-morbidities, and the residual effect from smoking would be 
minimised. Thus our findings in this main data analysis (e.g., RR 1.38) are preserved. 
However, the four studies [18, 19, 23, 24] with the crude RRs had the residual confounding 
and would have overestimated the RR. Adding them in the analysis (Supplementary Figure 1) 
could lead a higher RR in the pooled data than those of using their adjusted RRs. But we 
could not judge what effects of these crude RRs were on the finding of dose-response 
relationship between PD and dementia (Table 3). They should be interpreted cautiously, and 
the dose-response relationship needs further research, including more studies which presented 
adjusted RRs. Fourth, in nine studies which measured AD, only two [8, 20] presented the 
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results for the association of PD with AD.  Thus we are not able to analyse the evidence of 
the impact of PD on AD. Future studies on the topic should report results separately for AD 
and other type of dementia, apart from all dementia for meta-analysis. 
     As the studies included in our systematic review and meta-analysis were observational, we 
considered causal relationship between PD and dementia using the Bradford Hill Criteria [38] 
to provide evidence. 
How strong are the associations between PD and dementia?     
The studies under consideration demonstrated an overall moderate association between PD 
and dementia. Most of them showed a RR of dementia > 1.14 in people with PD [6-9, 20, 
21]. The cohort study conducted by Arrive et al, however, presents a non-significant inverse 
association between PD and incidence of dementia [10]. Chu et al [24] in a case-control study 
also found no significant association between PD and dementia, but data from two case-
control studies [20, 21] has demonstrated a stronger association between PD and dementia; 
their pooled OR of 2.25 (1.48-3.42). Overall, our meta-analysis of all data from eligible 
studies has demonstrated a significant influence of PD on increased risk of incident dementia 
(RR1.38, 1.01-1.90). 
How consistent are the reported studies? 
The results from the studies we identified were quite consistent, despite using different 
methodologies in conducting the studies. Of twelve studies reviewed, 11 reported a positive 
association of PD with dementia  [6-9, 18-24], and only one showed a non-significant inverse 
association [10]. Furthermore, the findings among these studies are consistent with those in a 




How specific is the response to proposed agents? 
The specificity criterion requires that a cause leads to one effect and not to multiple effects. 
PD increases the risks of cardiovascular disease [5], such as coronary heart disease [40] and 
stroke [41]. Nowadays it is not difficult to find that one risk factor causes multiple effects; for 
example, cigarette smoking increases the risk of lung cancer, but also cardiovascular disease 
and dementia [5, 40, 42]. Similar to other chronic non-communicable diseases, dementia 
could have more than one cause, i.e., multiple causes [31, 42]. Thus, the findings of our study 
could suggest that PD is also associated with increased risk of incident dementia. If a study 
reported the association of PD with dementia, other risk factors should be considered for 
analysis. The independent influence of PD on the risk of dementia needed to be identified 
through adjustment for other factors. Although most of the studies included in our meta-
analysis did not adjust for smoking, they adjusted for many other important factors such as 
socioeconomic status and co-morbidities, which were associated with smoking status. The 
pooled RR of 1.38 (1.01-1.90) for dementia in relation to PD appeared not to be substantially 
changed by other unmeasured confounders as those socioeconomic status and co-morbidities 
were adjusted, while PD shared common risk factors with a number of chronic diseases 
which include cardiovascular diseases [40, 43].  A significant association of PD with amyloid 
accumulation in AD patients’ brain was found with confirming an increase in 11C-PIB-PET 
uptake in Aβ vulnerable brain regions [44]. The current study could support an independent 
and potential causal effect of PD on dementia.  
 Is there a temporal relationship between exposure and response?  
Exposure must precede outcome and this is best ascertained in cohort studies. All five cohort 
studies had long-term follow up. After removing one study with the shortest follow-up period 
(8 years approximately) [6], the pooled RR was 1.20 (1.05-1.36), which did not reduce the 
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association of PD with increased risk of dementia.  Since most of the relevant studies, which 
we identified for review and meta-analysis, took chronic periodontitis in account in place of 
acute periodontitis, the exposure to PD should be earlier after experiencing certain duration 
(bacteria to deposit on tooth leading to plaque formation causing PD). Thus the temporal 
relationship has been ensured in our study. 
Is there an exposure-response relationship?  
The dose-response relationship between PD and dementia is observed in our pooled data 
from the studies, but it is not statistically significant, which could be due to the small number 
of studies included, of which half were those crude RRs. However, in a  meta-analysis of 
examining the association of tooth loss with dementia, Chen et al [39] found a significant 
dose-response. This could support our finding of the dose-response association of PD with 
dementia. 
 Is the association biologically plausible?  
There are several potential biological reasons for explaining the effect of PD on incident 
dementia. A plausible biologic mechanism has been proposed that periodontal infection lead 
to systemic inflammation, contributing to the pathogenesis of dementia [33, 45]. High 
inflammatory immune responses (C-reactive protein, tumor necrosis factor, interleukin-1, 
interleukin-6, a-1-antichymotrypsinin) can enter the blood brain barrier and influence priming 
or activation of the microglial cells in the cerebral regions which may contribute to the 
pathogenesis of dementia [33]. 
   Recent research showed that neuronal damage in AD pathogenesis is caused by 
porphyromonas gingivalis infection through the secretion of gingipains [34]. Porphyromonas 
gingivalis enters the brain by direct infection, cranial nerves and infection of monocytes 
which also effect on AD development [34].  
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    Other plausible mechanisms include shared genetic risk factors for PD and dementia. 
Porphyromonas gingivalis and host interactome related genes identified from genome-wide 
association studies (GWAS) overlap with susceptible genes involved in AD, suggesting 
that the Porphyromonas gingivalis interactome were significantly enriched in genes deposited 
in GWAS genes related to cognitive disorders, AD and dementia [46]. Also, it is possible that  
cardiovascular diseases,  which are caused by PD [5, 40],  link with dementia and converge 
into a common pathway leading to neurodegeneration and dementia [47].  
 Is the evidence coherent with knowledge of the natural history of disease?  
Previous studies showed that PD increased the risks of stroke [41] and cognitive 
impairment[14], which are associated with dementia. The existing evidence [39, 48]  has 
demonstrated that increased risk of dementia is associated with number of teeth lost, which is 
caused by PD. These could provide additional evidence in support of a causal association 
between PD and dementia.  
Is there experimental evidence?  
A number of animal studies have explored the relationship of PD with cognitive impairment 
and dementia. Kato et al [49] carried out an experiment of two groups of young rats; one 
group was made edentulous and other group was dentate. Both groups were given an 
identical nutritional powder. It was found that edentulous rats had poor spatial memory and 
decreased stimulated acetylcholine release in the parietal cortex.  In another study, 12 mice 
were orally infected by polymicrobial bacteria (Porphyromonas gingivalis, Treponema 
denticola, Tannerella forsythia, and Fusobacterium nucleatum), and oral pathogen 
Porphyromonas gingivalis was able to access the ApoE of the brain of mice which 
contributed to activation neuronal injury [50].  
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   Kawahata et al [51] observed a significant relationship between tooth loss and cognitive 
function in mice. They found that the loss of masticatory function in early life caused  
malnutrition and chronic stress that accelerated the aging process of the hippocampus [51]. In 
the amyloidogenic mouse model, dentate mice with experimental porphyromonas gingivalis 
periodontitis were found to develop impaired memory [52]. There was a significant increase 
in hippocampal, amyloid plaque loads in the whole brain and elevated levels of brain 
interleukin-1β and TNF-α [52]. Ilievski et al [53] have recently reported that long-term 
exposure to PD caused inflammation and neurodegeneration in the brain of mice, which 
similar to Alzheimer's disease in humans.  
          An experimental study demonstrated that periodontal pathogen could penetrate the 
blood-brain-barrier into the brain tissue [54]. Most of existing studies have shown that oral 
porphyromonas gingivalis infection in mice resulted in brain colonization and increased 
production of Aβ1–42, a component of amyloid plaques. Gingipains have been found to 
mediate toxicity of Porphyromonas gingivalis in endothelial cells, fibroblast and epithelial 
cells [34]. Dominy et al  [34] developed small inhibitor molecules to block gingipain to 
prevent neurodegeneration, which significantly reduced Porphyromonas gingivalis load in the 
mouse brain, and significantly decreased the host Aβ1–42 response to Porphyromonas 
gingivalis brain infection. These studies have provided evidence of plausible causal links 
between PD and AD/dementia in animal models. 
Does the evidence accord by analogy with that from other fields?  
Iwasaki et al [14] examined older people in the community in Japan, and found  that severe 
periodontitis and periodontal inflammation were associated with incident MCI. In a cohort 
study, Kaye et al [55] observed that the risk of cognitive decline over a decade increased by 
2–5% for every tooth that had progression of alveolar bone loss or probing pocket depth. The 
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association of tooth loss with increased risk of dementia have been confirmed in two 
systematic literature reviews [39, 48]. These have supported our findings of significant 
influence of PD on increased risk of dementia. 
Implications  
Our study has demonstrated that PD could be significantly associated with increased risk of 
incident dementia. It has projected the number of dementia cases to be saved through 
reducing the prevalence of PD in the world. If the current prevalence of PD in the world were 
halved, 0.85 million dementia cases would be saved based on our conservative estimation of 
RR of 1.18 for dementia in relation to PD from the cohort studies, or 1.70 million dementia 
cases would be saved if we used an estimation of RR of 1.38 from both the cohort studies and 
the case-control studies. Treating patients with PD could help reduce the risk of dementia [7]. 
Population-based prevention of PD and improved strategies can minimize dementia burden. 
All these would reduce huge economic burden and decrease financial constraint in health-
care systems. Oral hygiene habits, including regular brushing and dental visits can reduce the 
risk of PD and should thus be promoted as public health interventions to reduce incident 
dementia in the world. Dental care must be included in the wider care plan for the general 
population, to improve oral health throughout each individual’s life course, minimizing the 
negative effect of PD on the quality of life and reducing the potential risk of dementia in later 
life. It is imperative that all health and allied healthcare professionals, including dental teams, 
continue to promote and implement guidelines for the delivery of oral health that are tailored 
to support the various stages of dementia prevention.  
In conclusion, our study could provide evidence of significant and positive association of PD 
with increased risk of incident dementia. PD is a potential modifiable risk factor for dementia 
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and AD. Globally reducing PD through timely intervention, enhanced screening services and 
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Figure 1: Flow chart for literature search, selection and inclusion of studies for review 
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Figure 2: Forest plot for the pooled relative risk (RR) of PD and dementia risk  
NOTE: Weights are from random effects analysis
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Table 1: Evaluation of the study quality using Newcastle-Ottawa Scales (NOS) 
Cohort studies 
 
Selection of cohort  Chen  
et al [8] 
Lee YL  
et al [7] 
Lee YT 
 et al [6] 
Tzeng  
et al [9] 
Arrive 
 et al [10] 
1 Representativeness of the exposed 
cohort      
2  Selection of the non-exposed cohort      
3  Ascertainment of exposure      
4  Demonstration that outcome of interest 
was not present at start of study     
 
Comparability of cohorts 
1  Comparability of cohorts on the basis 
of the design or analysis      
Outcome 
1  Assessment of outcome       
2 Was follow-up long enough for 
outcomes to occur      
3 Complete follow up- all subjects 
accounted for      
Total score: 9/9 9/9 9/9 9/9 8/9 
Case –control studies 
 
Selection of  case-control  Holmer 




et al [18] 
Gil Montoya 




et al [23] 
Stein et al [22] 
1 Is the case definition adequate?        
2 Representativeness of the cases        
2 
 
3 Selection of Controls        
4 Definition of Controls        
Comparability 
1  Comparability of cases and controls on 
the basis of the design or analysis        
 
Exposure 
1  Ascertainment of exposure        
2  Same method of ascertainment for 
cases and controls     
   
3  Non-Response rate        
















Table 2: Pooled risk of dementia in people with PD according to the continents where the studies were undertaken 
 


















Categorized country by continents 
Asia [6-9] 4 4 6 225,594 6542 1.20 1.08-1.33 
Europe  [10, 20, 21] 3 1 7 1034 283 1.38 0.84-2.27 
 
Table 3: Dose –response between severity of periodontal disease and risk of dementia* 
 
Periodontal disease (PD) 
















* Dose- response studies:  [7, 10, 19, 21, 23, 24] 
**PD severity levels: 
  0= Reference (REF): no PD (including minor PD [19, 21, 24]) 
  1= Moderate PD: bleeding, calculus, gingivitis, shallow pockets. 
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The adjusted HR for 
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patients (n=312) with tooth 
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-Moderate PD: 1.10 (0.58-1.68)  
 





Philip dental hospital 
were invited (not 
under current dental 
treatment). 
 
PD =3;  
-Deep pockets/severe PD=4 
       
              Crude data 








0 0 1 
1 5 7 
2 5 5 
3 24 26 
4 13 11 
 
 
De Souza et al 





case-control study  
 
Mean ages: 75.17 
years in cases and 




recruited from the 
Cognitive Neurology 
and Behavior Group 
of the Neurology 
Department of the 
University of Sao 
Paulo.  
 
Controls were older 
people without AD 





GBI, PPD and CAL 
 
Severity of PD was 
defined according to 




29 AD cases and 30 





MMSE score for severity. 
 
           Crude data 
 


















   
 
One way ANOVA and non-
parametric tests (Chi-
square and Fisher’s exact 
tests) were used. 
 
Adjusted RR was not 
presented. 
 
RRs* in AD patients compared 
with control group were as 
follows:  
 
-Mild PD: 2.12 (1.15-2.63) 
 
-Moderate PD:1.13(0.25-2.32)  
 











Bramanti et al 









IRCSS staying at 
“Neurolesi Bonini-
Pulejo” in Messina 
having mean age in 
VaD group was 
86.7+6.2 years and 
control group was 







BOP and PPD 
 




Imaging evidence of 
cerebrovascular disease and 
additional clinical features, 
MMSE (Italy version) was 
checked by specialist to 
grade cognitive and 
functional impairment of 
VaD patients. 
 


















Chi square and Fisher exact 
test were applied for 
categorical variables 
 
Adjusted RR was not 
presented. 
 
RR*  in VaD patients compared 
with control group was as 
follows: 
BOP positive: 4.22 (3.10-5.03)  
 
Gil-Montoya et 










PPD, CAL and BI  
 
Degree of PD was 
 
180 cases (159 dementia 
from mild to severe and 21 
MCI) and 229 controls 
 
Multiple logistic regression 
analysis adjusted for age, 
gender, education, 
 








Cases were recruited 
from the Neurology 




patients being seen in 
primary healthcare, 
for problems other 




defined by the 
percentage of sites 
with CAL >3 mm as 
follows: 
- 0% = absent;            - 
0–32% = mild; 
- 33–66% = moderate; 
- 67–100% = severe 
 
Dementia: 







smoking, alcohol, BI, PI, 
PD, CAL, number of teeth, 











-Moderate CAL: 1.89 (1.13-
2.69) 
 
-Severe  CAL: 1.75 (1.11-2.46) 
 
 
















teaching hospitals of 
Xinjiang medical 
university from 






CPI, BOP, GI, CAL 
and Probing Depth. 
 
 




Clinical diagnostic criteria 
using MMSE for severity 
 
In their research thesis [37] 
, it was reported that  
percentage of periodontitis 
as follows: 
 














5  24 
 
One way ANOVA was 
used in the study,  
 






RRs* in AD patients compared 
with control group were as 
follows: 
 
-Moderate PD: 3.15 (1.62-4.57)   





















Subjects are aged 50-
80 years. 
 
Cases were screened 




recruited by a 

















154 cases (including 52 
participants with AD, 51 
with MCI and 51 with 
SCD) and 76 controls.  
 
All cases: 
ICD-criteria (10th revisions) 
including AD using NIA-
AA diagnostic guidelines; 






regression adjusted for age, 
gender, marital status, 
education, smoking, body 




RR* in AD patients compared 
with control group was 3.05 
(4.07 - 4.70) for those with more 
than 1 tooth with PPD ≥6mm.  
 
Abbreviations: AAP- clinical criteria of American Academy of Periodontology, AD- Alzheimer’s disease, ANOVA- Analysis of variance, BI- Bleeding index, BOP-Bleeding 
on Probing, BMI- Body mass index, CAL/AL – clinical attachment loss,  CP - chronic periodontitis, CPI- Community periodontal index, DSM-III R- Diagnostic and 
Statistical, Manual of Mental Disorders, Third Edition, Revised, DSM IV - Diagnostic and Statistical Manual of Mental Disorders criteria, fourth edition, GBI-Gingival 
bleeding index , GI-gingival index, HR- Hazard ratio, ICD-9-CM - International Classification of Diseases, Ninth Revision, Clinical Modification, ICD-10 -International 
Statistical Classification of Diseases and Related Health Problems 10th revision diagnostic criteria,  LHID- Longitudinal Health Insurance Database, MABL- Marginal 
alveolar bone loss, MCI- Mild cognitive impairment, MMSE - Mini Mental State Examination, NIA-AA National Institute on Aging and Alzheimer's Association guidelines, 
NINCDS-ADRDA - National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer´s Disease and Related Disorders Association, NINDS-AIREN - 
National Institute of Neurological Disorders and Stroke and Association Internationale pour la Recherché et l'Enseignement en Neurosciences, NHIRD- National Health 
Insurance Research Database,  OR- odds ratio, PD-  periodontal disease, PI-Plaque Index PPD- probing pocket depth, RR-relative risk, SCD-subjective cognitive decline, 
VaD- Vascular dementia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
* Based on the original data, we calculated crude OR and converted OR to RR for dementia, AD and VaD based on following formula [27]:  
RR =            odds ratio_______ 
14 
 
           1- risk0 + risk0 x odds ratio 
 
 




NOTE: Weights are from random effects analysis
.
.
Overall  (I-squared = 97.0%, p = 0.000)
Chu (2014) moderate PD
Subtotal  (I-squared = 80.9%, p = 0.000)
Subtotal  (I-squared = 56.7%, p = 0.014)
Cohort studies
Jureti (2016) moderate PD
Arrive (2012) moderate PD in high education
Holmer (2018)
Bramanti (2015)
De Souza (2014) moderate PD
Lee YL (2017) mild PD with intensive treatment
Lee YL (2017) moderate PD with tooth extraction
Gil-Montoya (2015) moderate PD
Jureti (2016) severe PD
Arrive (2012) severe PD in low education
Arrive (2012) moderate PD in low education
Case Control studies
Tzeng (2016)
Gil-Montoya (2015) severe PD
De Souza (2014) mild PD
De Souza (2014) severe PD





Chu (2014) severe PD
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